Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:59 AM
Ignite Modification Date:
2025-12-25 @ 4:59 AM
NCT ID:
NCT02445118
Eligibility Criteria:
Inclusion Criteria:
* Female,
* Between 35 and 75 years of age,
* Well controlled blood pressure,
* Able to sign an informed consent
Exclusion Criteria:
* Patients with active infection,
* Patients with a body weight change of greater than 5% throughout the 16 weeks of their participation,
* Patients with a BMI of greater than 30,
* Patients with a collagen vascular disease,
* Patients with end-stage organ failure (advanced COPD, CRF, CHF),
* Patients with lymphedema or mastectomy or axillary lymph node dissection, Patients who smoke,
* Patients that have undergone deep chemical peels, lasers, Ultherapy, Thermage, other light or energy based procedures to the dorsum of the hands one year prior,
* Patients who have taken any medication or oral supplements for the previous 4 weeks that could prolong bleeding time (e.g; Aspirin, Plavix, nutritional supplements starting with G, omega-3 , fish oil, etc)
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
35 Years
Maximum Age:
75 Years
Study:
NCT02445118
Study Brief:
Protocol Section:
NCT02445118